On Monday, Nuvation Bio Inc (NYSE: NUVB) was 3.07% up from the session before settling in for the closing price of $2.61. A 52-week range for NUVB has been $1.35 – $4.16.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -510.95%. With a float of $229.10 million, this company’s outstanding shares have now reached $335.25 million.
In an organization with 51 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -32.69%, operating margin of -5541.88%, and the pretax margin is -21940.68%.
Nuvation Bio Inc (NUVB) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Nuvation Bio Inc stocks. The insider ownership of Nuvation Bio Inc is 32.13%, while institutional ownership is 43.31%. The most recent insider transaction that took place on Nov 11 ’24, was worth 162,883. In this transaction CEO, ANHEART THERAPEUTICS LTD. of this company sold 56,361 shares at a rate of $2.89, taking the stock ownership to the 3,866,228 shares. Before that another transaction happened on Oct 08 ’24, when Company’s Director bought 100,000 for $2.20, making the entire transaction worth $220,000. This insider now owns 100,000 shares in total.
Nuvation Bio Inc (NUVB) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -510.95% per share during the next fiscal year.
Nuvation Bio Inc (NYSE: NUVB) Trading Performance Indicators
You can see what Nuvation Bio Inc (NUVB) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 9.57. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 417.20.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.17, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.58 in one year’s time.
Technical Analysis of Nuvation Bio Inc (NUVB)
Let’s dig in a bit further. During the last 5-days, its volume was 1.64 million. That was better than the volume of 1.55 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 18.36%. Additionally, its Average True Range was 0.16.
During the past 100 days, Nuvation Bio Inc’s (NUVB) raw stochastic average was set at 35.03%, which indicates a significant increase from 28.71% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.56% in the past 14 days, which was lower than the 69.48% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.57, while its 200-day Moving Average is $2.86. However, in the short run, Nuvation Bio Inc’s stock first resistance to watch stands at $2.76. Second resistance stands at $2.82. The third major resistance level sits at $2.93. If the price goes on to break the first support level at $2.59, it is likely to go to the next support level at $2.48. Assuming the price breaks the second support level, the third support level stands at $2.42.
Nuvation Bio Inc (NYSE: NUVB) Key Stats
There are 336,567K outstanding shares of the company, which has a market capitalization of 901.15 million. As of now, sales total 0 K while income totals -75,800 K. Its latest quarter income was 730 K while its last quarter net income were -41,210 K.
